Antitrust: Commission sends Statement of Objections to Teva on 'pay for delay' pharma agreement
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Pfizer and Teva face new drug delay action - Global Competition Review
Update On The Teva Copaxone EU Case. The EU Commission Issues A Statement Of Objections Against Teva Over Alleged Anti-Competitive Conduct Consisting Of Misuse Of Divisional Patents And A Disparagement Campaign Against
Teva Is Easy Pill to Swallow - WSJ
Statement by Executive Vice-President Margrethe Vestager on the Commission decision to fine Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - PubAffairs Bruxelles
Judge Narrows Antitrust Case Against Teva Over Gilead HIV Drugs -
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Case studies in Strategy: Teva
Violetta Meli on LinkedIn: Update on the Teva Copaxone EU case. The EU Commission issues a Statement…
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion - The New York Times
Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva - JUVE Patent
Brussels' Teva probe reveals dark side of patent protections | Financial Times
Teva asks high court to overturn recent GSK skinny label loss
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Copaxone not dead yet as Teva appeal lives on | Evaluate
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
Teva Q1 2023 Earnings: A Mix Of Challenges And Opportunities | Seeking Alpha
Antitrust: Commission fines Teva and Cephalon €60.5 million
Gilead And Teva's HIV Antitrust Trial Begins
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva must face government's kickback claims over Copaxone - judge | Reuters
